Research and application of NVP-BEZ235 in lung cancer / 国际肿瘤学杂志
Journal of International Oncology
;
(12): 383-385, 2017.
Article
in Chinese
| WPRIM
| ID: wpr-620922
ABSTRACT
NVP-BEZ235 is a newly developed dual phosphatidyl linositol kinase 3-kinase (PI3K) and mammalian target of rapamycin (mTOR) inhibitor.Studies have revealed that NVP-BEZ235 combinate with other drugs were effective in the treatment of lung cancer.NVP-BEZ235 might have a potential application value for the treatment of lung cancer of EGFR mutation subtype and KRAS mutation subtype.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Journal of International Oncology
Year:
2017
Type:
Article
Similar
MEDLINE
...
LILACS
LIS